Bolt Biotherapeutics (FRA:6LP) Total Stockholders Equity : €95.83 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bolt Biotherapeutics Total Stockholders Equity?

Bolt Biotherapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €95.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bolt Biotherapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €2.51. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bolt Biotherapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.19.

Bolt Biotherapeutics Total Stockholders Equity Historical Data

The historical data trend for Bolt Biotherapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bolt Biotherapeutics Total Stockholders Equity Chart

Bolt Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-41.26

-86.27

221.36

161.90

103.38

Bolt Biotherapeutics Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															147.28	131.19	120.18	103.38	95.83

Bolt Biotherapeutics (FRA:6LP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bolt Biotherapeutics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(95.826	-	0)	/	38.1277
	=	2.51

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bolt Biotherapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.656	+	15.346)	/	95.826
	=	0.19

Bolt Biotherapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bolt Biotherapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bolt Biotherapeutics (FRA:6LP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bolt Biotherapeutics Inc (FRA:6LP) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BOLT:USA 6LP:Germany

Address

900 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.boltbio.com

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Bolt Biotherapeutics (FRA:6LP) Headlines

No Headlines